REPLIGEN CORP Income Taxes Paid
REPLIGEN CORP (RGEN) reported Income Taxes Paid of $20.93 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-26
- REPLIGEN CORP income taxes paid, net for the quarter ending 2020-03-31 was $1.76M, a 66.45% increase year-over-year.
- REPLIGEN CORP income taxes paid, net for the quarter ending 2019-12-31 was $2.30M, a 148.27% increase year-over-year.
- REPLIGEN CORP income taxes paid, net for the quarter ending 2019-09-30 was $1.50M, a 9.69% decline year-over-year.
- REPLIGEN CORP income taxes paid, net for the quarter ending 2019-06-30 was $1.65M, a 216.70% increase year-over-year.
- REPLIGEN CORP income taxes paid, net for fiscal 2025 was $20.93M, a 8.42% increase from fiscal 2024.
- REPLIGEN CORP income taxes paid, net for fiscal 2024 was $19.30M, a 28.52% decline from fiscal 2023.
- REPLIGEN CORP income taxes paid, net for fiscal 2023 was $27.00M, a 21.43% decline from fiscal 2022.
- REPLIGEN CORP income taxes paid, net for fiscal 2022 was $34.37M, a 108.08% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $20.93M 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | $19.30M 10-K · filed 2026-02-26 | $19.30M 10-K · filed 2025-03-14 | |||
| 2023-12-31 | $27.00M 10-K · filed 2026-02-26 | $26.96M 10-K · filed 2024-02-22 | |||
| 2022-12-31 | $34.37M 10-K · filed 2025-03-14 | ||||
| 2021-12-31 | $16.52M 10-K/A · filed 2024-11-18 | ||||
| 2020-12-31 | $10.28M 10-K · filed 2023-02-22 | ||||
| 2020-03-31 | $1.76M 10-Q · filed 2020-05-06 | $4.05M derived: sum of 2 quarters · filed 2022-02-17 | $5.56M derived: sum of 3 quarters · filed 2022-02-17 | $7.21M derived: sum of 4 quarters · filed 2022-02-17 | |
| 2019-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $3.80M derived: sum of 2 quarters · filed 2022-02-17 | $5.45M derived: sum of 3 quarters · filed 2022-02-17 | $6.50M 10-K · filed 2022-02-17 | |
| 2019-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $3.15M derived: sum of 2 quarters · filed 2019-10-31 | $4.21M 10-Q · filed 2019-10-31 | $5.13M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $2.71M 10-Q · filed 2019-08-01 | $3.63M derived: sum of 3 quarters · filed 2021-02-24 | $5.29M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $1.05M 10-Q · filed 2020-05-06 | $1.98M derived: sum of 2 quarters · filed 2021-02-24 | $3.64M derived: sum of 3 quarters · filed 2021-02-24 | $4.16M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $926.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $2.59M derived: sum of 2 quarters · filed 2021-02-24 | $3.11M derived: sum of 3 quarters · filed 2021-02-24 | $4.05M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.18M derived: sum of 2 quarters · filed 2019-10-31 | $3.12M 10-Q · filed 2019-10-31 | $3.59M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-06-30 | $521.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $1.46M 10-Q · filed 2019-08-01 | $1.92M derived: sum of 3 quarters · filed 2020-02-26 | $3.33M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-03-31 | $937.00K 10-Q · filed 2019-05-09 | $1.40M derived: sum of 2 quarters · filed 2020-02-26 | $2.81M derived: sum of 3 quarters · filed 2020-02-26 | ||
| 2017-12-31 | $466.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $1.87M derived: sum of 2 quarters · filed 2020-02-26 | $4.02M 10-K · filed 2020-02-26 | ||
| 2017-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $3.56M 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | $2.15M 10-Q · filed 2018-08-02 | ||||
| 2016-12-31 | $3.99M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |